current user: public




Query: 3elj_A mol:protein length:369 Mitogen-activated protein kinase 8, from PDB0516

Results of FFAS03 search in PDB0516
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .
# Score Template Links and tools%idFirst GPLGSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLELast
1 -144.0003elj_A mol:protein length:369 Mitogen-activated protein kinase 8  ali model  100  1GPLGSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 369
2 -144.0002g01_A mol:protein length:370 Mitogen-activated protein kinase 8  ali model follow..  99  1.....MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 364
3 -143.0003vuh_A mol:protein length:370 Mitogen-activated protein kinase 8  ali model follow..  96  1.....MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 364
4 -143.0003vum_A mol:protein length:370 Mitogen-activated protein kinase 8  ali model follow..  95  1.....MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 364
5 -143.0002xrw_A mol:protein length:371 MITOGEN-ACTIVATED PROTEIN KINASE 8  ali model follow..  97  3......SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 365
6 -143.0004l7f_A mol:protein length:367 Mitogen-activated protein kinase 8  ali model follow..  98  1.........SLDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDWR 360
7 -143.0003npc_A mol:protein length:364 Mitogen-activated protein kinase 9  ali model follow..  83  1.....MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMDWE 364
8 -142.0003e7o_A mol:protein length:360 Mitogen-activated protein kinase 9  ali model follow..  83  1.......GSHMDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD.. 360
9 -142.0003v3v_A mol:protein length:379 Mitogen-activated protein kinase 8  ali model follow..  96  1.....MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLP 364
10 -141.0002xs0_A mol:protein length:386 MITOGEN-ACTIVATED PROTEIN KINASE 8  ali model follow..  97  1...GSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 366
11 -140.0005awm_A mol:protein length:394 Stress-activated protein kinase JNK  ali model follow..  76  10PRGSHRTMTTAQHQHYTVEVGDTNFTIHSRYINLRPIGSGAQGIVCAAYDTITQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIGLLNAFTPQRNLEEFQDVYLVMELMDANLCQVIQMDLDHDRMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKADCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYTENVDIWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQLGTPSPSFMQRLQPTVRNYVENRPRYTGYSFDRLFPDGLFPNDNNQNSRKASDARNLLSKMLVIDPEQRISVDEALKHEYINVWYDAEEVDAPAPEPYDHSVDEREHTVEQWKELIYEEVMDYE 379
12 -139.0003fv8_A mol:protein length:355 Mitogen-activated protein kinase 10  ali model follow..  93  1.....MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAXXXXX---------DEREHTIEEWKELIYKEVMNSE 355
13 -128.0003tti_A mol:protein length:464 Mitogen-activated protein kinase 10  ali model follow..  91  34AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE 402
14 -123.0003coi_A mol:protein length:353 Mitogen-activated protein kinase 13  ali model follow..  46  3.......SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLDKAAKSYIQSLPQTPRKDFTQLFPRA------------SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ-PFDDSLEHEKLTVDEWKQHIYKEIVNFS 351
15 -123.0004iz5_A mol:protein length:356 Mitogen-activated protein kinase 1  ali model follow..  39  3............GGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLEEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 351
16 -122.0004o6e_A mol:protein length:368 Mitogen-activated protein kinase 1  ali model follow..  39  3......SSSSGLVPRGSHMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 357
17 -122.0004i5h_A mol:protein length:359 Mitogen-activated protein kinase 1  ali model follow..  39  1.......SNAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVADLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKILDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 354
18 -122.0003zu7_A mol:protein length:365 MITOGEN-ACTIVATED PROTEIN KINASE 1  ali model follow..  38  1.......AAMAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 354
19 -121.0004o2z_A mol:protein length:377 Mitogen-activated protein kinase 3, putative  ali model follow..  33  11QGNQELSVPKIVGDFKVYNVSGSPFEVPSKYTLLKILGMGAYGIACSCLDGDTGEKVSIKKCRDVFRDVEDGKRVLREIDMMRFFHHENLLNVVNILPPLREYHSFEDVYVVTPLMDVDMNVVLRQVLEESHMQYFVYQILRGLKYLHSANVAHRDLKPANLVTNISCELKIIDFGLSRSVDVPSELTDYVITRWYRPPELLLENNYSTAVDIWSVGCIFAEMYNRKPVFPGRNTMDQLRMIAQHIGKPPASIVE--HREALEKLNELP-DGSLNIPKLVPGLA----------GNTEGIDFLSKMWTLDPSKRPTAADMLAHPYLAHLHDEEDEPTCPC-PFLWAHESTPMGVSELRRAFWADIVDYN 370
20 -121.0004myg_A mol:protein length:372 Mitogen-activated protein kinase 13  ali model follow..  47  9VPRGSHMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLDKAAKSYIQSLPQTPRKDFTQLFPRA------------SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ-PFDDSLEHEKLTVDEWKQHIYKEIVNFS 364
21 -121.0004qp1_A mol:protein length:369 Mitogen-activated protein kinase 1  ali model follow..  38  2....GSMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 358
22 -121.0004h3q_A mol:protein length:362 Mitogen-activated protein kinase 1  ali model follow..  38  4.......AAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGNLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 357
23 -121.0001tvo_A mol:protein length:368 Mitogen-activated protein kinase 1  ali model follow..  38  2.......AAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 355
24 -120.0001wzy_A mol:protein length:368 Mitogen-activated protein kinase 1  ali model follow..  38  3LGSDELMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 363
25 -120.0004qny_A mol:protein length:354 Mitogen activated protein kinase, putative  ali model follow..  32  1.........GMPATKSLAELQAEVCRLDDRYLLERIIGAGSYGVVIRARDTKSDNRVAMKRVNKEFEEVILAKRILREIKLLAHFNDDNIIGLRNILTP-EDPENFDHFYIVMDIMETDLKQVLRQELTEAHIQFFIYQALRALHIIHSAGVIHRDITPANILVNTNCDLKICDFGLAKEENDQEYMTDYVTMRWYRAPELVMEDDYSAQIDVWGIGCILGELLGSRPLFQGKDRVNQLDKIVDVIGTPSEEDINSVSSAAQKYLKKKSHRPQADWRQRYPTA------------SPEALDLLRHMLVFNPKRRITVLQAMRHPFLEQLHDDADDNLSYA-LFRFDENE-QKTIVDVKRAIYEESVKFH 352
26 -120.0001pme_A mol:protein length:380 ERK2  ali model follow..  39  9VPRGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYLVTHLMGADLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 369
27 -119.0003gcp_A mol:protein length:360 Mitogen-activated protein kinase 14  ali model follow..  47  1.......GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSLESRDLLIDEWKSLTYDEVISFV 349
28 -119.0002fsl_X mol:protein length:367 Mitogen-activated protein kinase 14  ali model follow..  47  2.......ASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSSESRDLLIDEWKSLTYDEVISFV 350
29 -119.0002ojg_A mol:protein length:380 Mitogen-activated protein kinase 1  ali model follow..  39  9VPRGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 369
30 -119.0004geo_A mol:protein length:367 Mitogen-activated protein kinase 14  ali model follow..  46  2.......ASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIAANWHYNQTVDIWSVGCIMAELLTGRTLFPGTDAADQLKLILRLVGTPGAELLKKISESARNAIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSFESRDLLIDEWKSLTYDEVISFV 350
31 -119.0003p4k_A mol:protein length:370 Mitogen-activated protein kinase 14  ali model follow..  47  2....AAMMSQERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLAQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSFESRDLLIDEWKSLTYDEVISFV 353
32 -118.0001oz1_A mol:protein length:372 Mitogen-activated protein kinase 14  ali model follow..  47  2..GRSGSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSFESRDLLIDEWKSLTYDEVISFV 355
33 -118.0003gc8_A mol:protein length:370 Mitogen-activated protein kinase 11  ali model follow..  47  2..SHMLEMSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISEHARTYIQSLPPMPQKDLSSIFRGA------------NPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAEP--YDESVEAKERTLEEWKELTYQEVLSFK 355
34 -118.0002zoq_A mol:protein length:382 Mitogen-activated protein kinase 3  ali model follow..  37  15GEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRA-STLEAMRDVYIVQDLMETDLYKLLKQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINMKARNYLQSLPSKTKVAWAKLFPKS------------DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEE-PFTFAMELDDLPKERLKELIFQETARFQ 375
35 -118.0001cm8_A mol:protein length:367 PHOSPHORYLATED MAP KINASE P38-GAMMA  ali model follow..  45  3......SPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLSDEAKNYMKGLPELEKKDFASILTNA------------SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK--YDDSFDDVDRTLDEWKRVTYKEVLSFK 352
36 -118.0003e92_A mol:protein length:371 Mitogen-activated protein kinase 14  ali model follow..  47  5HHLHHHGMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSFESRDLLIDEWKSLTYDEVISFV 360
37 -117.0003dt1_A mol:protein length:383 Mitogen-activated protein kinase 14  ali model follow..  46  11RGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSFESRDLLIDEWKSLTYDEVISFV 366
38 -116.0003oz6_A mol:protein length:388 Mitogen-activated protein kinase 1, serine/th  ali model follow..  34  1....................GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSHENIVNLLNVLRA----DNDRDVYLVFDYMETDLHAVIRNILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFDDQPILTDYVATRWYRAPEILLGSKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESISPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRK 375
39 -116.0004ewq_A mol:protein length:383 Mitogen-activated protein kinase 14  ali model follow..  46  11NLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--YDQSFESRDLLIDEWKSLTYDEVISFV 366
40 -116.0003oht_A mol:protein length:389 p38a  ali model follow..  46  17AAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMSHEARNYINSLPQMPKRNFADVFIGA------------NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDEPESEP--YDQSFESRQLEIEEWKRLTYEEVCSFE 372
41 -114.0002b9f_A mol:protein length:353 Mitogen-activated protein kinase FUS3  ali model follow..  37  3....................KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP-DSFENFNEVYIIQELMQTDLHRVISQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESSGMTEYVATRWYRAPEVMLTSKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHDNDLRCISPRAREYIKSLPMYPAAPLEKMFPRV------------NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPSFFEFDHYKEALTTKDLKKLIWNEIFS.. 353
42 -113.0003pg1_A mol:protein length:362 Mitogen-activated protein kinase, putative (M  ali model follow..  30  3.........QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH-FEEPAMHKLYLVTELMRTDLAQVIHDVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSPSARDYLRSLSNVPARAWTAVVPTA------------DPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLS--ERFHFDESVTDVYDMHKIFTAEVERFN 361
43 -113.0003nie_A mol:protein length:429 MAP2 kinase  ali model follow..  33  2........SSGRENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIP-EDLLKFDELYIVLEIADSDLKKLFKIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKQLTSHVVTRWYRAPELILLQNYTNSIDIWSTGCIFAELLNMFPLFPGKSNRDQLNIIFNVIGTPPEEDLKCIKQEVIKYIKLFPTRDGIDLSKKYSSI------------SKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMVLSETQLRYIFLKEIQSFH 407
44 -113.0004ic7_A mol:protein length:442 Mitogen-activated protein kinase 7  ali model follow..  38  27PAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLEHQYFMTEYVATRWYRAPELMLSLEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVAERVRAYIQSLPPRQPVPWETVYPGA------------DRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP-PFDFAFDREALTRERIKEAIVAEIEDFH 391
45 -113.0003n9x_A mol:protein length:432 Phosphotransferase  ali model follow..  32  1.........MSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP-DDLLKFDELYIVLEIADSDLKKLFKIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKQLTSHVVTRWYRAPELILLQNYTKSIDIWSTGCIFAELLNMFPLFPGKSNRDQLNIIFNIIGTPTEDDLKNIKPEVIKYIKLFPHRKPINLKQKYPSI------------SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFH 402
46 -112.0002i6l_A mol:protein length:320 Mitogen-activated protein kinase 6  ali model follow..  31  1..................SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSLTELNSVYIVQEYMETDLANVLEGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTDLVLKIGDFGLARIMDPHGHLSEGLVTKWYRSPRLLLSPNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI------------SREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI................................ 320
47 -110.0003rp9_A mol:protein length:458 Mitogen-activated protein kinase  ali model follow..  33  25QEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP-KDVEKFDELYVVLEIADSDFKKLFRVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYKRQLTGHVVTRWYRAPELILLQNYTEAIDVWSIGCIFAELLNRGPLFPGSSCFDQLNVIFNILGTPSEEDIEALKEDAKRYIRIFPKREGTDLAERFPAS------------SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYH 443
48 -92.6003e3p_A mol:protein length:360 Protein kinase, putative Glycogen synthase ki  ali model follow..  27  1......GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYT-LGERDRRDIYVVMEYVPDTLHRCCRVAPPPILIKVFLFQLIRSIGCLHSVNVCHRDIKPHNVLVNADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSTDVDLYNSKGIPSNVFSDHSLKD------------AKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNPEDLFRFLPNEIEVMSEAQKAKLVRK..... 360
49 -91.7004md7_E mol:protein length:391 Casein kinase II subunit alpha  ali model follow..  21  16.......NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRKPFFHGHDNYDQLVRIAKVLGTEDYDYIDKYNELDPRFNDILGRHSRKRWERFV-------HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSANMMSGISSVP-EPEPLGPLAGEPVIAAA 376
50 -90.9003ofm_A mol:protein length:350 Casein kinase II subunit alpha`  ali model follow..  22  16......VNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKIL-----KPVKKKKIKREVKILENLRGTNIIKLIDTVKDP---VSKTPALVFEYINNTDFKQLY-QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRRPFFHGQDNYDQLVRIAKVLGTEELYGYLK-IDLDPHFNDILGQHSRKRWENFI-------HSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSA-DNAVLSSGLTAA.................. 349
51 -90.0004md8_E mol:protein length:391 Casein kinase II subunit alpha  ali model follow..  21  16.......NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGPNIITLADIVKDP---VSRTPALVFEHVNNTDEKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRKPFFHGHDNYDQLVRIAKVLGTEDLYDYID-IELDPRFNDILGRHSRKRWERFV-------HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSS------MPGGSTPVSSANMMSGISSVPTP 361
52 -89.8002zjw_A mol:protein length:340 Casein kinase II subunit alpha  ali model follow..  23  20......VNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRKPFFHGHDNYDQLVRIAKVLGTEDLYDYID-IELDPRFNDILGRHSRKRWERFV-------HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG................................ 340
53 -89.5003u87_A mol:protein length:349 Casein kinase II subunit alpha  ali model follow..  22  15......VNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRKPFFHGHDNYDQLVRIAKVLGTEDYDYIDKYNELDPRFNDILGRHSRKRWERFV-------HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPCA-DNAVLSSGLTAA.................. 348
54 -89.3003eb0_A mol:protein length:383 Putative uncharacterized protein  ali model follow..  30  1......................GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDYFSVIVNPSQNKYLNVIMEYVPDTLHKVLKRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV--RFPTLKAKDWRKILPEGT-----------PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNPQLFNFSPYELSIPGNVLNRILPKNFSPNY 381
55 -89.3003e3b_X mol:protein length:339 Casein kinase II subunit alpha`  ali model follow..  23  22.......NSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKIL-----KPVKKKKIKREVKILENLRGTNIIKLIDTVKDP---VSKTPALVFEYINNTDFKQLY-QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRRPFFHGQDNYDQLVRIAKVLGTEELYGYLK-IDLDPHFNDILGQHSRKRWENFI-------HSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ.................................. 339
56 -88.8001o9u_A mol:protein length:350 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  26  8................ATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFAFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHA.... 348
57 -87.7001gng_A mol:protein length:378 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  25  2.KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHA.... 357
58 -87.4004dit_A mol:protein length:382 Glycogen synthase kinase-3 beta  ali model follow..  25  10......KDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILI........ 356
59 -86.3002pvh_A mol:protein length:352 Casein kinase II subunit alpha  ali model follow..  22  25.......NVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKIL-----KPVKKKKIKREIKILQNLCGPNIVKLLDIVRD----QHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQYDYSLDMWSLGCMFAGMIFRKPFFYGHDNHDQLVKIAKVLGTDGLNAYLN-IELDPQLEALVGRHSRKPWLKFM-------NADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTRA.............................. 346
60 -86.1004nm0_A mol:protein length:389 Glycogen synthase kinase-3 beta  ali model follow..  25  29...SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHA.... 382
61 -85.7001r0e_A mol:protein length:391 Glycogen synthase kinase-3 beta  ali model follow..  25  3......MSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHARI.. 355
62 -83.9003say_A mol:protein length:430 Glycogen synthase kinase-3 beta  ali model follow..  24  27.KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHARIQA 386
63 -83.7004ptc_A mol:protein length:441 Glycogen synthase kinase-3 beta  ali model follow..  24  42.KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHARIQA 401
64 -83.4004e7w_A mol:protein length:394 Glycogen Synthase Kinase 3  ali model follow..  28  37.........................QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGANYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN--YMEHKFPQIRPHPFSKVF-----------RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGPPLFNWTKEELSVRPDLISRLVPQHAEAEL 371
65 -82.5005air_A mol:protein length:430 LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROT  ali model follow..  25  39...SIDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHA.... 392
66 -81.9004bgq_A mol:protein length:304 CYCLIN-DEPENDENT KINASE-LIKE 5  ali model follow..  29  12............................NKFEILGVVGEGAYGVVLKCRHKETHEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR------GKLYLVFEYVEKNMLELLEEGVPPEKVKSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARSEGNNANYDEEVATRWYRSPELLLGAPYGKSVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPSEQMKLFYSNPRFHGLRFPAVNHPQ----------SLERRYLGILNSVLLDLMKNLLKLDPADRYLTEQCLNHPTFQTQ........................................ 301
67 -80.9004acc_A mol:protein length:465 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  25  60.KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHA.... 415
68 -79.5004f99_A mol:protein length:361 Cell division cycle 7-related protein kinase  ali model follow..  21  11..................KLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGQDNVMGVKYCFRKN------DHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKYALVDFGLAQGTHDTQQVAPRAGTPGFRAPEVLTKCNQTTAIDMWSAGVIFLSLLSGRPFYKASDDLTALAQIMTIRGSRETIQAAKTAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS....................................... 360
69 -78.9004agu_A mol:protein length:311 CYCLIN-DEPENDENT KINASE-LIKE 1  ali model follow..  26  1..........................MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK------RRLHLVFEYCDHTVLHELDRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTPSDYYDDEVATRWYRSPELLVG-QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDEDMEPLELKFPNI------------SYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYFQ.................... 311
70 -78.8002w96_B mol:protein length:306 CELL DIVISION PROTEIN KINASE 4  ali model follow..  34  4............................SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEHPNVVRLMDVCA-TSRTDREIKVTLVFEHVDQDLRTYLDK-LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR---GAFPPRGPRPVQSVVPEM------------EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE................................... 300
71 -78.3004aaa_A mol:protein length:331 CYCLIN-DEPENDENT KINASE-LIKE 2  ali model follow..  32  19............................EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK------KRWYLVFEFVDHTILDDLELGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAPGEVYDDEVATRWYRAPELLVG-KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEKEREPLERRYPKL------------SEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM......................................... 306
72 -78.2003nup_A mol:protein length:307 Cell division protein kinase 6  ali model follow..  34  11............................QQYECVAEIGEGAYGKVFKARDKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLEHPNVVRLFDVCT-VSRTDRETKLTLVFEHVDQDLTTYLDKGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDI------------DELGKDLLLKCLTFNPAKRISAYSALSHPYFQ.......................................... 301
73 -76.9001bi7_A mol:protein length:326 CYCLIN-DEPENDENT KINASE 6  ali model follow..  33  11............................QQYECVAEIGEGAYGKVFKARDKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLEHPNVVRLFDVCT-VSRTDRETKLTLVFEHVDQDLTTYLDK-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDI------------DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN.................................. 309
74 -76.5003zdu_A mol:protein length:325 CYCLIN-DEPENDENT KINASE-LIKE 3  ali model follow..  29  3............................EMYETLGKVGEGSYGTVMKCKHKNTGQIVAIKIFYERPEQSV-NKIAMREIKFLKQFHHENLVNLIEVFRQK------KKIHLVFEFIDHTVLDELQHGLESKRLRKYLFQILRAIDYLHSNNIIHRDIKPENILVSQSGITKLCDFGFARTLAPGDIYDDEVATRWYRAPELVLK-SYGKPVDIWALGCMIIEMATGNPYLPSSSDLDLLHKIVLKVGNLSPHLQNIFSKSPIFAGVVLPQVQHKNARKKYPKL------------NGLLADIVHACLQIDPADRISSSDLLHHEYFTR......................................... 289
75 -76.2003g33_A mol:protein length:308 Cell division protein kinase 4  ali model follow..  34  9............................SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-LPISTVREVALLRRLEHPNVVRLMDVCA-TSRTDREIKVTLVFEHVDQDLRTYLDKALPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR---GAFPPRGPRPVQSVVPEM------------EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE................................... 308

FFAS is supported by the NIH grant R01-GM087218-01
8 2 8 8 8   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Friedberg I, Jaroszewski L, Ye Y, Godzik A. The interplay of fold recognition and experimental structure determination in structural genomics. Curr Opin Struct Biol. 2004 Jun;14(3):307-12.